| Literature DB >> 30578215 |
Matthias Loeckx1,2,3, Roberto A Rabinovich4, Heleen Demeyer1,2,5, Zafeiris Louvaris1,6, Rebecca Tanner7, Noah Rubio4, Anja Frei8, Corina De Jong9, Elena Gimeno-Santos5,10,11, Fernanda M Rodrigues1,2, Sara C Buttery7, Nicholas S Hopkinson7, Gilbert Büsching8, Alexandra Strassmann8, Ignasi Serra5,10,11, Ioannis Vogiatzis6,12, Judith Garcia-Aymerich5,10,11, Michael I Polkey7, Thierry Troosters1,2.
Abstract
BACKGROUND: Telecoaching approaches can enhance physical activity (PA) in patients with chronic obstructive pulmonary disease (COPD). However, their effectiveness is likely to be influenced by intervention-specific characteristics.Entities:
Keywords: COPD; outcome and process assessment (health care); patient adherence; patient satisfaction; physical activity; smartphone; telemedicine
Year: 2018 PMID: 30578215 PMCID: PMC6320438 DOI: 10.2196/mhealth.9774
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Overview of the intervention; 1=sending of “steps data” to smartphone (through Bluetooth); 2=data sent to central database; 3=coach is able to access database; 4=coach is able to manually adjust goals, 5=accessing & closing the different tasks on the smartphone app (automated messages); i.e., (from left to right); morning goal, send activity in the evening, daily feedback (from Monday to Saturday) and weekly feedback (only on Sunday) tasks.
Figure 2Division (into 3 groups) of patients based on total duration and number of contacts between patients and coach. Min=minutes; #=number of contacts; n=number of patients in each group.
Baseline characteristics of the completers of the trial.
| Variables | Intervention completers (n=159) |
| Age in years, mean (SD) | 66 (8) |
| Gender (male), n (%) | 89 (64) |
| BMIa (kg/m2), mean (SD) | 26.9 (5.3) |
| FEV1b predicted (%), mean (SD) | 53.9 (19.9) |
| 6MWDc (m), mean (SD) | 442 (107) |
| 6MWD predicted (%), mean (SD) | 70.3 (16.5) |
| CATd score, mean (SD) | 13 (8) |
| QFe (kg), mean (SD) | 31.5 (10.9) |
| PAf (steps per day), median (P25-P75)g | 4272 (2783-5768) |
aBMI: body mass index.
bFEV1: forced expiratory volume in 1 second.
c6MWD: 6-minute walking distance; 6MWD was missing in 2 patients.
dCAT: chronic obstructive pulmonary disease (COPD) assessment test.
eQF: quadriceps force; QF was not measured in 2 centers and QF was missing in 27 patients.
fPA: physical activity; valid PA measurements were present in 140 patients.
g25th and 75th percentiles (P25-P75).
Figure 3Boxplots depicting the usefulness score (0-10 Likert scale) of the different parts of the intervention from the patients’ perspective. “app” between brackets represents messages displayed on the smartphone app.
Overview of the different components of the intervention. Definition of actual usage of the different components of the intervention of all completers (n=159 patients) and the minimum and maximum values one can achieve in terms of actual usage were reported when applicable. Actual usage and possible minimum-maximum are expressed as median (P25-P75) days per week for the step counter and the daily tasks on the app. Weekly feedback is expressed as median (P25-P75) percent of weeks in the intervention.
| Components of the intervention | Actual usage | |||
| Definition of actual usage | Median (p25-p75)a | Possible minimum-maximum | ||
| One-to-one interview with coach discussing motivation, barriers, favorite activities, and strategies to become more active | N/Ab | N/A | N/A | |
| Step counter (Fitbug Air; days per week) | A day with ≥70 steps recorded | 6.3 (5.8-6.8) | 0-7 | |
| Send activity data task (days per week) | Patient closes task | 4.1 (2.4-5.6) | 0-7 | |
| Looking to the daily goal task (days per week) | Patient closes task | 4.1 (2.1-5.9) | 0-7 | |
| Looking at the daily feedback task (days per week) | Patient closes task | 2.2 (0.7-4.1) | 0-6 | |
| Looking at the weekly feedback task (% of weeks in the intervention) | Patient closes task | 55 (29-78) | 0-100 | |
| A booklet containing home exercises | N/A | N/A | N/A | |
| Weekly group text messages with activity proposals sent by the coach | N/A | N/A | N/A | |
| Contact with the coaches, which was triggered in the case of nonactual usage with wearing the step counter, failure to transmit data, or failure to progress | N/A | N/A | N/A | |
a25th and 75th percentiles (P25-P75).
bN/A: not applicable.
Figure 4Contact time throughout the intervention (only including centers with more than 20 patients). The black bars represent the mean contact time (in min per week) per patient from the first 10 patients that were recruited in each center. White bars represent the mean contact time (in min per week) per patient from the patients that were recruited at a later stage. P value indicates difference between the total cumulated contact time over the 12 weeks between patients recruited in early stage versus later stage.
Patient baseline characteristics according to the total contact time (only including patients with valid PA measurement; n=140); data are expressed as mean (SD) unless stated otherwise. P value indicates differences between the 3 contact time groups.
| Variables | Low contact time (n=49) | Medium contact time (n=46) | High contact time (n=45) | |
| Age in years, mean (SD) | 65 (7) | 65 (10) | 68 (6) | .16 |
| Gender (male), n (%) | 28 (57) | 34 (74) | 27 (60) | .20 |
| BMIa (kg/m2), mean (SD) | 27.8 (5.3) | 26.1 (4.4) | 27.0 (6.4) | .35 |
| FEV1b predicted percentage, mean (SD) | 59.5 (22.6) | 54.1 (16.5) | 49.1 (20.5)j | .04 |
| 6MWDc (m), mean (SD) | 444 (100) | 459 (101) | 411 (113) | .09 |
| 6MWD predicted percentage, mean (SD) | 71.5 (14.5) | 71.2 (15.0) | 67.4 (19.6) | .29 |
| CATd score, median (p25-p75)e | 10 (6-17) | 13 (7-19) | 16 (10-21) | .11 |
| QFf (kg), mean (SD) | 33.1 (13.2) | 31.2 (10.0) | 29.2 (10.5) | .33 |
| PAg (steps per day), median (p25-p75) | 4542 (3387-5587) | 4377 (3016-6723) | 3186 (2375-5339) | .15 |
| Contact time first 4 weeks in minutes, median (p25-p75) | 0 (0-5)h | 10 (5-20)i | 50 (20-85)j | .005 |
aBMI: body mass index.
bFEV1: forced expiratory volume in 1 second.
c6MWD: 6-minute walking distance; 6MWD was missing in 2 patients.
dCAT: chronic obstructive pulmonary disease (COPD) assessment test.
e25th and 75th percentiles (P25-P75).
fQF: quadriceps force; QF was not measured in 2 centers and QF was missing in 27 patients.
gPA: physical activity.
hIndicates statistical significance (P<.05) between low versus medium contact time groups.
iIndicates statistical significance (P<.05) between medium versus high contact time groups.
jIndicates statistical significance (P<.05) between low versus high contact time groups.
Figure 5Change in physical activity (PA; mean [SE]) across groups of patients according to total contact time; adjusted for age, baseline functional exercise capacity, baseline forced expiratory volume in 1 second, baseline symptom score and number of acute exacerbations in the previous 12 months. P value (P for trend) indicates difference in intervention effect between patients divided based on total contact time, after adjusting for the covariates. Data are based on Actigraph measurements and include 140 patients. Unadjusted scores were mean(SD) +1489 (SD 2310) steps per day, +907 (SD 2306) steps per day and +193 (SD 2375) steps per day in low, medium and high contact time groups, respectively.
Patient characteristics according to the total actual usage score (3 groups only including patients with valid physical activity measurement by actigraph, n=140); data are expressed as mean (SD) unless stated otherwise. P value indicates differences between the 3 actual usage groups.
| Variables | Low actual usage, <47% of usage (n=47) | Medium actual usage, 47% to 75% of usage (n=46) | High actual usage, >75% of usage (n=47) | |
| Age in years, mean (SD) | 66 (8) | 66 (9) | 65 (8) | .76 |
| Gender (male), n (%) | 31 (66) | 29 (63) | 29 (62) | .91 |
| BMIa in kg per m2, mean (SD) | 27.5 (5.3) | 27.6 (6.5) | 26.0 (4.3) | .34 |
| FEV1b predicted percentage, mean (SD) | 54.4 (20.3) | 55.2 (19.5) | 53.5 (21.6) | .92 |
| 6MWDc (m), mean (SD) | 431 (106) | 432 (105) | 454 (107) | .50 |
| 6MWD predicted percentage, mean (SD) | 69 (17) | 69 (17) | 72 (16) | .61 |
| CATd score, median (p25-p75)e | 14 (7-19) | 13 (6-19) | 12 (7-21) | .94 |
| QFf (kg), mean (SD) | 32.0 (10.8) | 30.0 (12.9) | 31.1 (9.4) | .73 |
| PAg (steps per day) median (p25-p75) | 4369 (2868-5672) | 3850 (2380-6108) | 4540 (2940-6731) | .49 |
aBMI: body mass index.
bFEV1: forced expiratory volume in 1 second.
c6MWD: 6-minute walking distance; 6MWD was missing in 2 patients.
dCAT: chronic obstructive pulmonary disease (COPD) assessment test.
e25th and 75th percentiles (P25-P75).
fQF: quadriceps force; QF was not measured in 2 centers and QF was missing in 27 patients.
gPA: physical activity; valid PA measurements was present in 140 patients.
Figure 6Change in physical activity (PA; mean [SE] across groups of patients according to overall actual usage score; adjusted for age, baseline functional exercise capacity, baseline forced expiratory volume in 1 second, baseline symptom score and number of acute exacerbations in the previous 12 months. P value (P for trend) indicates difference in intervention effect between patients divided based on the total actual usage score, after adjusting for the covariates. Data are based on Actigraph measurements and include 140 patients. Unadjusted scores were mean(SD) +777 (SD 2767) steps per day, +1159 (SD 2720) steps per day and +679 (SD 2075) steps per day in low, medium and high actual usage groups, respectively.